Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2

Not Applicable

• Conditions: COVID-19; SARS-CoV2; Coronavirus Infections; SARS Virus; Coronaviridae Infections; Nidovirales Infections; Betacoronavirus

• Registration Number: RPCEC00000342
• Lead Sponsor: ational Center for Scientific Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-10-15
• Study Start: 2020-11-06
• Results First Posted: 2020-12-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Hospitalization patients convalescient with SARS-CoV 2, bewteen 40 and 80 years , both sexes, signed informed consent.

Exclusion Criteria

1) Patients with uncontrolled hypertiroidism
2) Patients with deficit of glucose-6-phosphateo-deshidrogenase
3) Non transmissible cronic diseases
4) Oncological patients
5) Patients with psiquiatric diseases
6) Surgery
7) Patients use inmunosupresant or patients with trasplant
8) Patiens with coagulation , trombocitopenia or active bleed
9) Allergic patients
10) Patients participate in other clinical trials 3 months before

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Physical-nutritional status (Body mass index [(weight (kg) / height (m)) measured as Poor, Normal, Excessive]; Arm circumference [Assessment of atrophy measured as Presence or Not]; Grip strength [Evolution of sarcopenia measured as Presence or not]).Measurement time: Baseline and, at the end of the 4th week of treatment